Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pAL120-TK Citations (1)

Originally described in: High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity.
King GD, Muhammad AK, Xiong W, Kroeger KM, Puntel M, Larocque D, Palmer D, Ng P, Lowenstein PR, Castro MG J Virol. 2008 May . 82(9):4680-4.
PubMed Journal

Articles Citing pAL120-TK

Articles
ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers. Day EK, Campbell A, Pandolf A, Rogerson T, Zhong Q, Xiao A, Purow B, Lazzara MJ. Mol Ther. 2021 Apr 7;29(4):1585-1601. doi: 10.1016/j.ymthe.2020.12.019. Epub 2020 Dec 15. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.